These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7351116)

  • 1. Metabolic disposition of methyldopa in hypertensive and renal-insufficient children.
    O'Dea RF; Mirkin BL
    Clin Pharmacol Ther; 1980 Jan; 27(1):37-43. PubMed ID: 7351116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolism of 14 C-labelled -methyldopa in normal and hypertensive human subjects.
    Au WY; Dring LG; Grahame-Smith DG; Isaac P; Williams RT
    Biochem J; 1972 Aug; 129(1):1-10. PubMed ID: 4646774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of methyldopa.
    Myhre E; Rugstad HE; Hansen T
    Clin Pharmacokinet; 1982; 7(3):221-33. PubMed ID: 7047042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugation of methyldopa in renal failure.
    Myhre E; Stenbaek O; Brodwall EK; Hansen T
    Scand J Clin Lab Invest; 1972 Apr; 29(2):195-9. PubMed ID: 5029323
    [No Abstract]   [Full Text] [Related]  

  • 5. Absolute configuration of alpha-methyldopamine formed metabolically from alpha-methyldopa in man.
    Marshall KS; Castagnoli N
    J Med Chem; 1973 Mar; 16(3):266-70. PubMed ID: 4733109
    [No Abstract]   [Full Text] [Related]  

  • 6. Alpha-methyldopa disposition in mothers with hypertension and in their breast-fed infants.
    White WB; Andreoli JW; Cohn RD
    Clin Pharmacol Ther; 1985 Apr; 37(4):387-90. PubMed ID: 3838502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combined use of L-alpha-methyldopa hydrazine and methyldopa in the treatment of hypertension.
    Louis WJ; Vajda FJ; McNeil JJ; Doyle AE; Jarrott B
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():17-22. PubMed ID: 354826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentration of alpha-methyldopa and sulphate conjugate after oral administration of methyldopa and intravenous administration of methyldopa and methyldopa hydrochloride ethyl ester.
    Saavedra JA; Reid JL; Jordan W; Rawlins MD; Dollery CT
    Eur J Clin Pharmacol; 1975 Aug; 8(6):381-6. PubMed ID: 1233238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of conjugation and drug elimination in the human neonate.
    Cummings AJ; Whitelaw AG
    Br J Clin Pharmacol; 1981 Oct; 12(4):511-5. PubMed ID: 6117307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive therapy with timolol and alpha-methyldopa. A double-blind trial in patients with moderately severe hypertension.
    Lubbe WF
    S Afr Med J; 1976 Feb; 50(9):279-85. PubMed ID: 4898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the role of alpha-methyldopamine in the antihypertensive effect of alpha-methyldopa.
    Waldmeier P; Hedwal PR; Maître L
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(3):303-14. PubMed ID: 169487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma turnover of methyldopa in advanced renal failure.
    Myhre E; Brodwall EK; Stenbaek O; Hansen T
    Acta Med Scand; 1972 Apr; 191(4):343-7. PubMed ID: 5032679
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of methyldopa on renal function in patients with renal insufficiency.
    Brodwall EK; Myhre E; Stenbaek O; Hansen T
    Acta Med Scand; 1972 Apr; 191(4):339-41. PubMed ID: 5032678
    [No Abstract]   [Full Text] [Related]  

  • 14. A study of the disposition of alpha-methyldopa in newborn infants following its administration to the mother for the treatment of hypertension during pregnancy.
    Jones HM; Cummings AJ; Setchell KD; Lawson AM
    Br J Clin Pharmacol; 1979 Nov; 8(5):433-40. PubMed ID: 508547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The renal excretion of methyldopa.
    Myhre E; Brodwall EK; Stenbaek O; Hansen T
    Scand J Clin Lab Invest; 1972 Apr; 29(2):201-4. PubMed ID: 5029324
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolism of methyldopa in man after oral administration of the pivaloyloxyethyl ester.
    Vickers S; Duncan CA; Ramjit HG; Dobrinska MR; Dollery CT; Gomez HJ; Leidy HL; Vincek WC
    Drug Metab Dispos; 1984; 12(2):242-6. PubMed ID: 6144491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of alpha-methyldopa in kidney failure].
    Schrader K; Brass H; Renner D
    Klin Wochenschr; 1971 Dec; 49(24):1329-34. PubMed ID: 5138344
    [No Abstract]   [Full Text] [Related]  

  • 18. Alteration of methyldopa absorption, metabolism, and blood pressure control caused by ferrous sulfate and ferrous gluconate.
    Campbell N; Paddock V; Sundaram R
    Clin Pharmacol Ther; 1988 Apr; 43(4):381-6. PubMed ID: 3356082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined clinical and metabolic study of the effects of alpha-methyldopa on hypertensive patients.
    Prescott LF; Buhs RP; Beattie JO; Speth OC; Trenner NR; Lasagna L
    Circulation; 1966 Aug; 34(2):308-21. PubMed ID: 5969361
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet phenol sulfotransferase and erythrocyte catechol-O-methyltransferase activities: correlation with methyldopa metabolism.
    Campbell NR; Dunnette JH; Mwaluko G; Van Loon J; Weinshilboum RM
    Clin Pharmacol Ther; 1984 Jan; 35(1):55-63. PubMed ID: 6580988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.